Immunic Inc’s (IMUX) short interest has decreased by 7.19% since its last report, now standing at 6.57 million shares sold short, which is 5.55% of its float. This decline suggests a more bullish sentiment among investors compared to the previous report. The company’s short interest is also lower than its peer group average of 10.21%.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
What Does the Market Think About Immunic Inc?
Immunic Inc’s (IMUX) short interest has decreased by 7.19% since its last report, now standing at 6.57 million shares sold short, which is 5.55% of its float. This decline suggests a more bullish sentiment among investors compared to the previous report. The company’s short interest is also lower than its peer group average of 10.21%.